Levetiracetam Injection (Iv) Suppliers & Bulk Manufacturers
Available Forms: Injection (IV)
Available Strengths: 100 mg/mL
Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®
Category: Antipsychotropic Drugs
Levetiracetam Injection (IV) is available in Injection (IV) and strengths such as 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Levetiracetam Injection (IV) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Levetiracetam Injection (IV) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Levetiracetam, marketed globally under brands like Keppra®, is a widely prescribed anticonvulsant used for treating epilepsy. Available in the US and EU, Levetiracetam comes in oral tablets (250 mg–1000 mg), oral solution (100 mg/mL), and injectable forms. This drug is effective in managing partial, generalized, and myoclonic seizures in adults and children. Its high tolerability and minimal drug interactions make it a preferred option among neurologists. Pharmatradz.com helps you connect with certified global B2B suppliers of Levetiracetam API, formulations, and bulk stock across regulated markets. Source top-quality Levetiracetam from audited manufacturers via Pharmatradz.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Clorazepate Dipotassium
Strength:
3.75 mg, 7.5 mg, 15 mg, 5 mg, 10 mg, 20 mg
Form: Tablets, Capsules
Reference Brands: Tranxene (USA), Tranxilium(EU)
View DetailsLumateperone
Strength:
10.5 mg, 21 mg, 42 mg
Form: Capsules
Reference Brands: Caplyta (USA)
View DetailsAmoxapine
Strength:
25 mg, 50 mg, 100 mg, 150 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View DetailsAmisulpride
Strength:
5 mg/2 mL, 50 mg, 100 mg, 200 mg
Form: Tablets / injectable solutions
Reference Brands: Barhemsys (USA), Solian (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers